Formulation and delivery of itraconazole to the brain using a nanolipid carrier system

References

• WissingSAKayserOMüllerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
   PubMed Web of Science ®Google Scholar
• SeverinoPAndreaniTMacedoASCurrent state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug deliveryJ Drug Deliv2012201275089122175030
   PubMedGoogle Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254Suppl 1S131S15512460720
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm20022421–212112812176234
   PubMed Web of Science ®Google Scholar
• ChenWGuBWangHPanJLuWHouHDevelopment and evaluation of novel itraconazole-loaded intravenous nanoparticlesInt J Pharm20083621–213314018585448
   PubMed Web of Science ®Google Scholar
• MaertensJBoogaertsMThe place for itraconazole in treatmentJ Antimicrob Chemother200556Suppl 1i33i3816120632
   PubMedGoogle Scholar
• De BeuleKItraconazole: pharmacology, clinical experience and future developmentInt J Antimicrob Agents19966317518118611706
   PubMed Web of Science ®Google Scholar
• PardeikeJWeberSHaberTDevelopment of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary applicationInt J Pharm20114191–232933821839157
   PubMed Web of Science ®Google Scholar
• PeetersJNeeskensPTollenaereJPVan RemoorterePBrewsterMECharacterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7J Pharm Sci20029161414142212115841
   PubMed Web of Science ®Google Scholar
• AkkarAMüllerRHIntravenous itraconazole emulsions produced by SolEmuls technologyEur J Pharm Biopharm2003561293612837478
   PubMed Web of Science ®Google Scholar
• KimJKParkJSKimCKDevelopment of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled releaseInt J Pharm20103831–220921519747966
   PubMed Web of Science ®Google Scholar
• KethireddySAndesDCNS pharmacokinetics of antifungal agentsExpert Opin Drug Metab Toxicol20073457358117696807
   PubMed Web of Science ®Google Scholar
• PardridgeWMBlood-brain barrier deliveryDrug Discov Today2007121–2546117198973
   PubMed Web of Science ®Google Scholar
• HawkinsBTDavisTPThe blood-brain barrier/neurovascular unit in health and diseasePharmacol Rev200557217318515914466
   PubMed Web of Science ®Google Scholar
• BlasiPGiovagnoliSSchoubbenARicciMRossiCSolid lipid nanoparticles for targeted brain drug deliveryAdv Drug Deliv Rev200759645447717570559
   PubMed Web of Science ®Google Scholar
• KaurIPBhandariRBhandariSKakkarVPotential of solid lipid nanoparticles in brain targetingJ Control Release200812729710918313785
   PubMed Web of Science ®Google Scholar
• GabathulerRApproaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseasesNeurobiol Dis2010371485719664710
   PubMed Web of Science ®Google Scholar
• PardridgeWMBlood-brain barrier drug targeting: the future of brain drug developmentMol Interv200332901055114993430
   PubMedGoogle Scholar
• MiyamaTTakanagaHMatsuoHP-glycoprotein-mediated transport of itraconazole across the blood-brain barrierAntimicrob Agents Chemother1998427173817449661014
   PubMed Web of Science ®Google Scholar
• DuretCWauthozNSebtiTVanderbistFAmighiKNew inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisInt J Nanomedicine201275475548923093903
   PubMed Web of Science ®Google Scholar
• YangSCLuLFCaiYZhuJBLiangBWYangCZBody distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brainJ Control Release199959329930710332062
   PubMed Web of Science ®Google Scholar
• ZaraGPCavalliRFundaròABargoniACaputoOGascoMRPharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)Pharmacol Res199940328128610479474
   PubMed Web of Science ®Google Scholar
• RedmannSCharlesBGA rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosisBiomed Chromatogr200620434334816161186
   PubMed Web of Science ®Google Scholar
• NoackAHauseGMaderKPhysicochemical characterization of curcuminoid-loaded solid lipid nanoparticlesInt J Pharm2012423244045122197758
   PubMedGoogle Scholar
• VandammeTFAntonNLow-energy nanoemulsification to design veterinary controlled drug delivery devicesInt J Nanomedicine2010586787321042549
   PubMed Web of Science ®Google Scholar
• BabootaSShakeelFAhujaAAliJShafiqSDesign, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxibActa Pharm200757331533217878111
   PubMedGoogle Scholar
• HuFQYuanHZhangHHFangMPreparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterizationInt J Pharm20022391–212112812052697
   PubMed Web of Science ®Google Scholar
• VitorinoCCarvalhoFAAlmeidaAJSousaJJPaisAAThe size of solid lipid nanoparticles: an interpretation from experimental designColloids Surf B Biointerfaces201184111713021242064
   PubMed Web of Science ®Google Scholar
• NidhinMIndumathyRSreeramKNairBSynthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templatesBulletin of Materials Science2008319396
   Web of Science ®Google Scholar
• FreitasCMüllerRHEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
   Web of Science ®Google Scholar
• LiuJHuWChenHNiQXuHYangXIsotretinoin-loaded solid lipid nanoparticles with skin targeting for topical deliveryInt J Pharm2007328219119516978810
   PubMed Web of Science ®Google Scholar
• HelgasonTAwadTSKristbergssonKMcClementsDJWeissJEffect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)J Colloid Interface Sci20093341758119380149
   PubMed Web of Science ®Google Scholar
• DasSNgWKKanaujiaPKimSTanRBFormulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variablesColloids Surf B Biointerfaces201188148348921831615
   PubMed Web of Science ®Google Scholar
• SilvaACGonzález-MiraEGarcíaMLPreparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasoundColloids Surf B Biointerfaces201186115816521530187
   PubMed Web of Science ®Google Scholar
• VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release200495362763815023472
   PubMed Web of Science ®Google Scholar
• LvQYuAXiYDevelopment and evaluation of penciclovir-loaded solid lipid nanoparticles for topical deliveryInt J Pharm20093721–219119819429280
   PubMed Web of Science ®Google Scholar
• AbdelbaryGFahmyRHDiazepam-loaded solid lipid nanoparticles: design and characterizationAAPS PharmSciTech200910121121919277870
   PubMed Web of Science ®Google Scholar
• PatelKPadhyeSNagarsenkerMDuloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form designAAPS PharmSciTech201213112513322167415
   PubMed Web of Science ®Google Scholar
• XieSZhuLDongZPreparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acidsColloids Surf B Biointerfaces201183238238721215599
   PubMed Web of Science ®Google Scholar
• PriyankaKSathaliAAPreparation and evaluation of montelukast sodium loaded solid lipid nanoparticlesJ Young Pharm20124312913723112531
   PubMedGoogle Scholar
• MadanJPandeyRSJainVKatareOPChandraRKatyalAPoly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cellsNanomedicine20139449250323117045
   PubMed Web of Science ®Google Scholar
• ZhangHYaoMMorrisonRAChongSCommonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in ratsArch Pharm Res200326976877214560928
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de MendozaAPréatVMollinedoFBlanco-PrietoMJIn vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against gliomaJ Control Release2011156342142621821074
   PubMed Web of Science ®Google Scholar